-Dow Jones
HC Wainwright & Co. Maintains Buy on IGM Biosciences, Lowers Price Target to $76
HC Wainwright & Co. analyst Robert Burns maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and lowers the price target from $114 to $76.
Related Posts
Chevron, Amazon, Google Among The 5 Stock Plays For DOE’s Breakthrough Fusion Tech
The U.S. Department of Energy (DOE) and its National Nuclear Security Administration (NNSA) unveiled "a landmark achievement" Tuesday when it confirmed that a fusion ignition breakthrough at a California lab essentially proves that an unlimited clean energy source is indeed feasible.
Wells Fargo Maintains Equal-Weight on Duke Energy, Lowers Price Target to $103
Wells Fargo analyst Neil Kalton maintains Duke Energy (NYSE:DUK) with a Equal-Weight and lowers the price target from $111 to $103.
The Only ‘Cannabis’ Ad That Aired During Super Bowl: Willie Nelson, Skechers’ Hilarious ‘Legalize’ Commercial
The legendary, pot-smoking musical great teamed up with Skechers (NYSE: SKX) in an ad called “Legalize” - clearly a play on Willie’s long-standing belief that cannabis should be legalized across the country.